November 12, 2026 · Journal of the American College of Cardiology · DOI: 10.1016/j.jacc.2026.09.009

Antithrombotic Therapy Management After Left Atrial Appendage Closure: Current Regimens, Evolving Evidence, and the Control Group Dilemma.

Listen to this summary

This review examines which antithrombotic regimen is best after percutaneous left atrial appendage closure (LAAC), weighing the need to prevent device-related thrombosis (DRT) against the bleeding risk and the loss of benefit from avoiding long-term oral anticoagulation. The authors appraise evidence from small, heterogeneous trials (ANDES, ADALA) and a meta-analysis favoring DOAC over DAPT for lower DRT, and they note that current guideline regimens rest largely on device-specific protocols or low-certainty evidence. They propose a risk-tailored framework: intensify therapy early for device healing, reassess at 45 to 90 days to de-escalate, continue OAC or DAPT only for concomitant indications, and generally use OAC for definite or probable DRT, without basing decisions on the peridevice leak alone.

Carmelo Raffo, Antonio Greco, Kamil Bujak, Nicola Ammirabile, Costanza Bordonaro, Chiara Cosentino, Carmelo Cusmano, Luigi Cutore, Giacinto Di Leo, Simone Finocchiaro, Daniele Giacoppo, Maria Sara Mauro, Placido Maria Mazzone, Francesco Nasisi, Diego Nastasi, Riccardo Prezzavento, Giulia Puglisi, Pietro Redigolo, Paolo Sciacca, Marco Spagnolo, Davide Capodanno

This is one of 33,000+ journals available on OSLR. Try it free for 14 days.

Free 14-day trial. 33,000+ journals. Cancel anytime.

14-day free trial. No commitment.

“

"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."

Dr. Jennifer Thompson

Dr. Jennifer Thompson

Portland, OR

Stay current without falling behind

33,000+ journals. 3-minute audio summaries. Free for 14 days.

Download on the App StoreGet it on Google Play